e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Treatments, adherence and psychosocial aspects of cystic fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Development of Barrows Cards in enhancing self-management in Pediatric patient with Cystic Fibrosis
A. Bagnasco (Genoa, Italy), G. Aleo (Genoa, Italy), G. Catania (Genoa, Italy), M. Zanini (Genoa, Italy), L. Sasso (Genoa, Italy)
Source:
International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Session:
Treatments, adherence and psychosocial aspects of cystic fibrosis
Session type:
Thematic Poster
Number:
4522
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Bagnasco (Genoa, Italy), G. Aleo (Genoa, Italy), G. Catania (Genoa, Italy), M. Zanini (Genoa, Italy), L. Sasso (Genoa, Italy). Development of Barrows Cards in enhancing self-management in Pediatric patient with Cystic Fibrosis. 4522
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
A Telemonitoring Homecare Platform for patients with Pulmonary Fibrosis
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
The Effects of Nebulizer Cleaning and Disinfection Training On The Knowledge Levels and Practises of the Caregivers of Patients with Cystic Fibrosis
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020
Effects of Telerehabilitation on Peripheral Muscle Function in Pediatric Cystic Fibrosis Patients During Covid-19 Pandemic
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021
Does physiotherapy affect Lung Clearance Index in Cystic Fibrosis patients ?
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Collaborating with stakeholders to advance the National Patient Charter for Idiopathic Pulmonary Fibrosis in Ireland.
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017
Is Virtual Autonomous Physiotherapist Tele-rehabilitation Program feasible in Idiopathic Pulmonary Fibrosis?
Source: Virtual Congress 2020 – Muscle, exercise capacity and symptoms of chronic lung disease: a physio update
Year: 2020
Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019
Treatment of Idiopathic Pulmonary Fibrosis - Evidence to Decision Frameworks
Source: Guideline 2015
Year: 2015
GPs Meet Rare Lung Disorders Task Force factsheet: cystic fibrosis
Source: Breathe 2014; 10:345-347
Year: 2014
Cystic Fibrosis Patients Eligible for Modulator Drugs: Data from Cystic Fibrosis Registry of Turkey
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019
Patient And Carer Perceptions Regarding The Advanced Lung Disease Service – A New Model Of Integrated Respiratory And Palliative Care
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018
Report of the European Respiratory Society/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosis
Source: Eur Respir J 2016; 47: 420-428
Year: 2016
Evaluation of COPD Patient’s Relatives Assessment of Disease Awarness, Load of Care Giving and Loss of Workforce: Turkish Thoracic Society COPD Working Group.
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018
Implementing the International Committee on Mental Health in Cystic Fibrosis (ICMH) Guidelines: Practical complexities of managing mental health
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Comparison of the Cystic Fibrosis Questionnaire with the St George‘s Respiratory Questionnaire in adult patients with cystic fibrosis
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012
Assessment of Severe Asthma Management Practices among Pulmonologists and Allergists
Source: International Congress 2018 – Medical education via the web and the internet
Year: 2018
Aerobic and Breathing Exercises Improve Dyspnea, Exercise Capacity and Quality of Life in Idiopathic Pulmonary Fibrosis Patients: Systematic Review and Meta-Analysis.
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019
Ceremony for the ERS Idiopathic Pulmonary Fibrosis Research Award
Source: International Congress 2015 – IPF: an airway-derived disease?
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept